Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01328704 · ClinicalTrials.gov registry record
Evaluate the Change in Iron, Vitamin D, and C-Reactive Protein Level (CRP) in a 12 to 24 Week Period
A clinical trial of Anemia and Vitamin D Deficiency, sponsored by Avera McKennan Hospital & University Health Center.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT01328704: Completed study of Anemia and Vitamin D Deficiency, sponsored by Avera McKennan Hospital & University Health Center.
NCT01328704 is a study of Anemia and Vitamin D Deficiency that has completed, run by Avera McKennan Hospital & University Health Center. The registered enrollment target is 50 participants, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01328704, a study of Anemia and Vitamin D Deficiency, has completed, sponsored by Avera McKennan Hospital & University Health Center.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to observe changes in iron status and vitamin D status during a 12-24 week supervised training program, specifically males and females between the ages of 30 and 50 years old.
Primary Outcome
Serum iron levels
Conditions Studied
Study Locations (1)
South Dakota
- Avera Sports Institute - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-03 |
What the finished NCT01328704 record still lists
NCT01328704 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Anemia appearing as the primary indexed condition, and to 0 interventions.
NCT01328704 reports a single indexed study location in South Dakota.
Frequently Asked Questions
What is clinical trial NCT01328704 about?
NCT01328704 is a clinical study titled "Evaluate the Change in Iron, Vitamin D, and C-Reactive Protein Level (CRP) in a 12 to 24 Week Period". The purpose of this study is to observe changes in iron status and vitamin D status during a 12-24 week supervised training program, specifically males and females between the ages of 30 and 50 years old.
What is the current status of trial NCT01328704?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2012-01. Estimated completion is 2013-03.
What conditions does trial NCT01328704 study?
This clinical trial studies the following conditions: Anemia, Vitamin D Deficiency.
Who is sponsoring clinical trial NCT01328704?
This trial is sponsored by Avera McKennan Hospital & University Health Center, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01328704 being conducted?
This trial has 1 study location across South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01328704's enrollment target sits among peer trials
50 58th of 72 higher than 14 of 72 other Anemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
RECRUITING · Phase 2
-
Study of DISC-0974-201 in Participants With IBD and Anemia
RECRUITING · Phase 2
-
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RECRUITING · Phase 1
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
RECRUITING · Phase 3
-
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia